Table 2.
HuCV subtypes and NoV II genotypes | Total n = 1,121 N (%) |
<2 years n = 791 N (%) |
2–5 years n = 59 N (%) |
5–14 years n = 21 N (%) |
14–65 years n = 223 N (%) |
≥65 years n = 27 N (%) |
p-value |
---|---|---|---|---|---|---|---|
HuCV | 123 (11.0) | 94 (11.9) | 4 (6.8) | 2 (9.5) | 19 (8.5) | 4 (14.8) | 0.178 |
NoV GI | 2 (0.2) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0.193 |
SaV | 3 (0.3) | 2 (0.3) | 1 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.489 |
NoV GII | 118 (10.5) | 92 (11.6) | 2 (3.4) | 2 (9.5) | 18 (8.7) | 4 (14.8) | 0.063 |
GII.4 | 55 (4.9) | 42 (5.3) | 1 (1.7) | 2 (9.5) | 9 (4.0) | 1 (3.7) | 0.426 |
GII.3 | 28 (2.5) | 20 (2.5) | 0 (0.0) | 0 (0.0) | 6 (2.7) | 2 (7.4) | 0.154 |
GII.12 | 25 (2.2) | 24 (3.0) | 1 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.004 |
GII.17 | 8 (0.7) | 5 (0.6) | 0 (0.0) | 0 (0.0) | 2 (0.9) | 1 (3.7) | 0.503 |
GII.5 | 2 (0.2) | 1 (0.1) | 0 (0.0) | 0 (0.0) | 1 (0.5) | 0 (0.0) | 0.901 |
Significant differences are marked in bold